80
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Electrocatalytic Cascade Selective Approach to 3-Aryl-2'H,3H,4H-Spiro{Furo[2,3-с]Chromene-2,5'-Pyrimidine}-2',4,4',6'(1'H,3'H)Tetraones and Its Automatic Screening Docking Studies

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon &
Pages 8356-8370 | Received 28 Jun 2022, Accepted 12 Nov 2022, Published online: 05 Dec 2022
 

Abstract

The general electrocatalytic cascade approach was found to medicinally relevant spirobarbituric 2,3-dihydro-4H-furo[2,3-c]chromen-4-one scaffold. This new electrocatalytic fast and efficient reaction of benzylidenebarbiturates and 4-hydroxycoumarin in alcohols in the presence of alkali metal halides as mediators in an undivided cell results in the formation of the substituted unsymmetric spirobarbituric 2,3-dihydro-4H-furo[2,3-с]chromen-4-ones in 72–83% yields. This general and efficient approach avoids traditional recrystallization and chromatographic purification stages. According to screening molecular docking data, all synthesized compounds may be prominent for different medical applications, such as control pain, breast cancer therapies, and treatment of obesity, epilepsy, hypertension, cardiovascular disease and diabetes.

Disclosure statement

No potential conflict of interest was reported by the author.

Additional information

Funding

The reported study was funded by RFBR, project number 19-29-08013(Russian Foundation for Basic Research).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.